Effect of urinary protein C inhibitor on lipopolysaccharide-induced disseminated intravascular coagulation in rats

Thrombosis and Haemostasis

Volumn 84, Issue 1, 2000, Pages 54-58

  Fujita, Mitsugu ^a   Izutani, Wakako ^a   Komurasaki, Yoshikazu ^a  

^a JCR Pharmaceuticals Co Ltd   (Japan)

Author keywords

DIC; Experimental DIC in rat; Urinary protein C inhibitor

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHEMOTACTIC FACTOR; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; LIPOPOLYSACCHARIDE; PLASMA KALLIKREIN; PLASMINOGEN ACTIVATOR INHIBITOR 3; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; FEMORAL VEIN; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HYPERCOAGULABILITY; MALE; MONOCYTE; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RAT;

EID: 0033917083     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613967     Document Type: Article

References (29)

1. Espana F, Berrettini M, Griffin JH. Purification and characterization of plasma protein C inhibitor. Thromb Res 1989; 55: 369-84.
2. Suzuki K, Deyashiki Y, Nishioka J, Toma K. Protein C inhibitor: structure and function. Thromb Haemost 1989; 61: 337-42.
3. Stump DC, Thienpont M, Collen D. Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasma. J Biol Chem 1986; 261: 12759-66.
4. Heeb MJ, Espana F, Geiger M, Collen D, Stump DC, Griffin, JH. Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3. J Biol Chem 1987; 262: 15813-6.
5. Espana F, Gilabert J, Estelles A, Romeu A, Aznar J, Cabo A. Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen. Thromb Res 1991; 64: 309-20.
6. Laurell M, Christensson A, Abrahamsson PA, Stenflo J, Lilja H. Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J Clin Invest 1992; 89: 1094-101.
7. Rezaie AR, Cooper ST, Church FC, Esmon CT. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. J Biol Chem 1995; 270: 25336-9.
8. Suzuki K, Nishioka J, Kusumoto H, Hashimoto S. Mechanism of inhibition of activated protein C by protein C inhibitor. J Biochem 1984; 95: 187-95.
9. Suzuki K, Nishioka J, Hashimoto S. Protein C inhibitor. Purification from human plasma and characterization. J Biol Chem 1983; 258: 163-8.
10. Meijers JCM, Vlooswijk RAA, Kanters DHAJ, Messing M, Bouma BN. Identification of monoclonal antibodies that inhibit the function of protein C inhibitor. Evidence for heparin-independent inhibition of activated protein C in plasma. Blood 1988; 72: 1401-3.
11. Meijers JCM, Kanters DHAJ, Vlooswijk RAA, van Erp HE, Hessing M, Bouma BN. Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor. Biochemistry 1988; 27: 4231-7.
12. Pratt CW, Macik BG, Church FC. Protein C inhibitor: purification and proteinase reactivity. Thromb Res 1989; 53: 595-602.
13. Vicente V, Espana F, Tabernero D, Estelles A, Aznar J, Hendl S, Griffin JH. Evidence of activation of the protein C pathway during acute vascular damage induced by Mediterranean spotted fever. Blood 1991; 78: 416-22.
14. Cooper ST, Whinna HC, Jackson TP, Boyd JM, Church FC. Intermolecular interactions between protein C inhibitor and coagulation proteases. Biochemistry 1995; 34: 12991-7.
15. 1-antitrypsin for structure and function of serpins. Biochemistry 1989; 28: 8951-66.
16. Suzuki K, Deyashiki Y, Nishioka J, Kurachi K, Akira M, Yamamoto S, Hashimoto S. Characterization of a cDNA for human protein C inhibitor. A new member of the plasma serine protease inhibitor superfamily. J Biol Chem 1987; 262: 611-6.
17. 1-Antitrypsin and the serpins: variation and countervariation. Trends Biochem Sci 1985; 10: 20-4.
18. Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987; 79: 124-30.
19. Kagawa H, Komiyama Y, Nakamura S, Miyake T, Miyazaki Y, Hamamoto K, Masuda M, Takahashi H, Nomura S, Fukuhara S. Expression of functional tissue factor on small vesicles of lipopolysaccharide-stimulated human vascular endothelial cells. Thromb Res 1998; 91: 297-304.
20. Suzuki K, Kusumoto H, Nishioka J, Komiyama Y. Bovine plasma protein C inhibitor with structural and functional homologous properties to human plasma protein C inhibitor. J Biochem 1990; 107: 381-8.
21. Pratt CW, Church FC. Heparin binding to protein C inhibitor. J Biol Chem 1992; 267: 8789-94.
22. Sheffield WP, Wu YI, Blajchman MA. Antithrombin: Structure and Function. In: Molecular Basis of Thrombosis and Hemostasis. High KA, Roberts HR, eds. New York: Marcel Dekker Inc 1995; 355-77.
23. Rubin RN, Colman RW. Disseminated intravascular coagulation. Approach to treatment. Drugs 1992; 44: 963-71.
24. Lijnen HR, Van Hoef B, Collen D. Influence of cyanogen-bromide-digested fibrinogen on the kinetics of plasminogen activation by urokinase. Eur J Biochem 1984; 144: 541-4.
25. Wu HL, Chang BI, Wu DH, Chang LC, Gong CC, Lou KL, Shi GY. Interaction of plasminogen and fibrin in plasminogen activation. J Biol Chem 1990; 265: 19658-64.
26. Buller HR, Hobbelen PMJ, Princen AWN, Moelker HCT, ten Cate JW. The effects of antithrombin III, heparin and a novel heparinoid infusions on the bleeding tendency using an experimental model in the rat. Thromb Res 1983; 31: 787-97.
27. Schapira M, Despland E, Scott CF, Boxer LA, Colman RW. Purified human plasma kallikrein aggregates human blood neutrophils. J Clin Invest 1982; 69: 1199-202.
28. Jochum M, Machleidt W, Neuhof H, Fritz H. Proteinases. In: Pathophysiology of Shock, Sepsis, and Organ Failure. Schlag G, Redl H, eds. Berlin Heidelberg: Springer-Verlag 1993; 46-60.
29. Katsuura Y, Okamoto S, Ohno N, Wanaka K. Effects of a highly selective synthetic inhibitor of plasma kallikrein on disseminated intravascular coagulation in rats. Thromb Res 1996: 82: 361-8.